UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.

I discuss and analyze UNH's cautious FY2025 guidance, attributing lower bottom-line to various factors. Click here to read my ...

UnitedHealth earnings topped forecasts, but the Dow Jones member lowered the top end of its full-year outlook.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

Mizuho Securities analyst Ann Hynes has assigned their bullish stance on UNH stock, giving a Buy rating today. Ann Hynes has given her Buy ...

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of ...

Shares of UnitedHealth Group tumbled Tuesday as the company lowered its full-year outlook to reflect the impact of a February ...

UnitedHealth's lower 2025 earnings outlook than expected leads to a sell-off, affecting its managed care rivals like ...

Quarterly profit of $6.06 billion at the Minnetonka-based company beat analyst estimates on a per-share basis as revenue grew ...

What Are The Key Trends To Drive UnitedHealth’s Q3 Results? UnitedHealth should continue to benefit from an increase in total ...

UnitedHealth Group (UNH) stock is down more than 9% in early trading Tuesday, dragging the price-weighted Dow Jones Industrial Average into the red. The selloff comes as the health insurance ...